>FASTA: short reads of the global biotech ecosystem | Papers and patents, acquisitions and bankruptcies, biotech philosophy | Follow on LinkedIn, X, and Instagram.
It’s been a loooongggg break from posting, but I haven’t stopped reading and thinking about biotech. Let’s catch up on fertility, neurotech, longevity, and peptide startups:
Chinese billionaires have been ordering babies by the dozen, made through IVF and surrogacy.
RenewalBio makes “synthetic” embryos directly from stem cells.
Fairtility, the AI tool that enhances the work of embryologists.
Colossal Foundation donated $1.5M to George Church to make artificial wombs.
Becoming is an SF startup that builds exogenous placenta.
The DOE will train AI scientists on Federal scientific datasets.
DARPA’s new Generative Optogenetics (GO) Program.
Antitrust in the science instrument industry.
Sam Altman and Masayoshi Son’s new R&D company.
Flow Neuroscience’s transcranial stimulation device has been approved by the FDA.
Subscribe to read all 30 news about: a marketplace for non-human genomic data, the ozempic economy, the company cultivating pharma-grade shrooms, a phage therapy for obesity, betting on human enhancement, biotech new masculinity, endometriosis startups, quantum dots, health by subscription…
Keep reading with a 7-day free trial
Subscribe to Biopunk to keep reading this post and get 7 days of free access to the full post archives.